Lemaitre Vascular (LMAT) Total Liabilities (2010 - 2026)

Lemaitre Vascular (LMAT) has 17 years of Total Liabilities data on file, last reported at $222.9 million in Q1 2026.

• On a quarterly basis, Total Liabilities rose 6.94% year-over-year to $222.9 million in Q1 2026; TTM through Mar 2026 was $222.9 million, a 6.94% increase from a year earlier, with the FY2025 full-year figure at $222.2 million, up 3.56% from the prior year.
• Total Liabilities for Q1 2026 stood at $222.9 million, roughly flat from $222.2 million in the prior quarter.
• Over the last five years, Total Liabilities for LMAT reached as high as $222.9 million in Q1 2026 and fell as low as $34.7 million in Q1 2022.
• Historically, Total Liabilities has averaged $104.3 million across 5 years, with a median of $45.5 million in 2024.
• Across the five-year window, Total Liabilities tumbled 50.37% in 2022 and surged 393.5% in 2025, its largest moves.
• Year by year, Total Liabilities stood at $42.3 million in 2022, then gained by 15.62% to $48.9 million in 2023, then soared by 338.9% to $214.5 million in 2024, then grew by 3.56% to $222.2 million in 2025, then advanced by 0.33% to $222.9 million in 2026.
• Per Business Quant data, the three most recent Total Liabilities figures were $222.9 million in Q1 2026, $222.2 million in Q4 2025, and $219.1 million in Q3 2025.